Stockreport

Vaxart Announces Initiation of Sentinel Cohort for Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate [Yahoo! Finance]

Vaxart, Inc.  (VXRT) 
Last vaxart, inc. earnings: 3/19 04:01 pm Check Earnings Report
PDF — The sentinel cohort is being funded as part of the Phase 2b NextGen COVID-19 clinical trial, valued at up to $456 million through the Rapid Response Partnership Vehic [Read more]